These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 24119825)

  • 1. The enteroviruses: problems in need of treatments.
    Abzug MJ
    J Infect; 2014 Jan; 68 Suppl 1():S108-14. PubMed ID: 24119825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug discovery in enteroviral infections.
    Chen TC; Shih SR
    Infect Disord Drug Targets; 2011 Jun; 11(3):337-45. PubMed ID: 21488833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The life cycle of non-polio enteroviruses and how to target it.
    Baggen J; Thibaut HJ; Strating JRPM; van Kuppeveld FJM
    Nat Rev Microbiol; 2018 Jun; 16(6):368-381. PubMed ID: 29626210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enteroviruses in the early 21st century: new manifestations and challenges.
    Lugo D; Krogstad P
    Curr Opin Pediatr; 2016 Feb; 28(1):107-13. PubMed ID: 26709690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enteroviruses: epidemic potential, challenges and opportunities with vaccines.
    Jartti M; Flodström-Tullberg M; Hankaniemi MM
    J Biomed Sci; 2024 Jul; 31(1):73. PubMed ID: 39010093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The combination of pleconaril, rupintrivir, and remdesivir efficiently inhibits enterovirus infections in vitro, delaying the development of drug-resistant virus variants.
    Ianevski A; Frøysa IT; Lysvand H; Calitz C; Smura T; Schjelderup Nilsen HJ; Høyer E; Afset JE; Sridhar A; Wolthers KC; Zusinaite E; Tenson T; Kurg R; Oksenych V; Galabov AS; Stoyanova A; Bjørås M; Kainov DE
    Antiviral Res; 2024 Apr; 224():105842. PubMed ID: 38417531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute Flaccid Paralysis and Enteroviral Infections.
    Bitnun A; Yeh EA
    Curr Infect Dis Rep; 2018 Jun; 20(9):34. PubMed ID: 29959591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combating enterovirus replication: state-of-the-art on antiviral research.
    Thibaut HJ; De Palma AM; Neyts J
    Biochem Pharmacol; 2012 Jan; 83(2):185-92. PubMed ID: 21889497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseases.
    Mao Q; Wang Y; Bian L; Xu M; Liang Z
    Emerg Microbes Infect; 2016 Jul; 5(7):e75. PubMed ID: 27436364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent developments in antiviral agents against enterovirus 71 infection.
    Tan CW; Lai JK; Sam IC; Chan YF
    J Biomed Sci; 2014 Feb; 21(1):14. PubMed ID: 24521134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innate Immunity Evasion by Enteroviruses: Insights into Virus-Host Interaction.
    Lei X; Xiao X; Wang J
    Viruses; 2016 Jan; 8(1):. PubMed ID: 26784219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of viral capsid inhibitors in human enterovirus infection and associated diseases.
    Li C; Wang H; Shih SR; Chen TC; Li ML
    Curr Med Chem; 2007; 14(8):847-56. PubMed ID: 17430140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presentation, diagnosis, and management of enterovirus infections in neonates.
    Abzug MJ
    Paediatr Drugs; 2004; 6(1):1-10. PubMed ID: 14969566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of antiviral agents toward enterovirus 71 infection.
    Pourianfar HR; Grollo L
    J Microbiol Immunol Infect; 2015 Feb; 48(1):1-8. PubMed ID: 24560700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploration of the anti-enterovirus activity of a series of pleconaril/pirodavir-like compounds.
    Bernard A; Lacroix C; Cabiddu MG; Neyts J; Leyssen P; Pompei R
    Antivir Chem Chemother; 2015 Apr; 24(2):56-61. PubMed ID: 26071135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-Reactive Antibody Responses against Nonpoliovirus Enteroviruses.
    Rosenfeld AB; Shen EQL; Melendez M; Mishra N; Lipkin WI; Racaniello VR
    mBio; 2022 Feb; 13(1):e0366021. PubMed ID: 35038922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enterovirus infections with special reference to enterovirus 71.
    Hsiung GD; Wang JR
    J Microbiol Immunol Infect; 2000 Mar; 33(1):1-8. PubMed ID: 10806956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antivirals blocking entry of enteroviruses and therapeutic potential.
    Anasir MI; Zarif F; Poh CL
    J Biomed Sci; 2021 Jan; 28(1):10. PubMed ID: 33451326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of potentially life-threatening enterovirus infections with pleconaril.
    Rotbart HA; Webster AD;
    Clin Infect Dis; 2001 Jan; 32(2):228-35. PubMed ID: 11170912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2C protein of Enterovirus: key protein of viral replication and antiviral target.
    El Kazzi P; Yaacoub C; Fajloun Z; Vanelle P; Decoly E; Coutard B; Barral K
    Virologie (Montrouge); 2023 Jun; 27(3):35-49. PubMed ID: 37476987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.